Chondrosarcoma epidemiology and demographics: Difference between revisions
No edit summary |
Mahshid |
||
| Line 20: | Line 20: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Orthopedics]] | |||
Revision as of 02:48, 6 November 2017
|
Chondrosarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Chondrosarcoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Chondrosarcoma epidemiology and demographics |
|
Risk calculators and risk factors for Chondrosarcoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]
Overview
Chondrosarcoma is the second most common malignant primary tumor of bone. Men are slightly more affected with liposarcoma than women. It is most frequent in middle-aged and older adults.
Epidemiology and Demographics
Chondrosarcomas are malignant cartilaginous tumors that account for 20-27% of all primary malignant bone tumors. Chondrosarcoma is the second most common malignant primary tumor of bone.
Age
- Chondrosarcoma is most frequently diagnosed in patients in their 4th and 5th decades of life with an average age at diagnosis of 51.
Gender
- Men are slightly more affected with chondrosarcoma than women.